“People are not getting the same care”: health disparities and Parkinson’s
Author: Sophie BatesPublished: 20 August 2020
Prep: Cook: Serves:
Five experts discuss the health disparities faced by people with Parkinson’s, why healthcare inequalities have been neglected for so long – and what needs to change
A recent webinar hosted by US Parkinson’s charity Davis Phinney Foundation, in partnership with Dance for PD, invited a panel of experts to talk about the inequities in healthcare experienced by black, brown, indigenous, LGBTQ+, immigrant and refugee communities in the US. We share three key takeaways from their discussion.
David Leventhal, programme director of Dance for PD, kicked off the talk by recognising that the lack of diversity at events, classes and support groups for Parkinson’s is not “an accident” but “the result of deeply rooted systemic health and cultural inequalities, inequities and disparities”.
“As somebody who leads dance classes for people with Parkinson’s around the US, I witness inspiring participation from thousands of people, but a notable lack of racial and cultural diversity in those programmes,” says Leventhal. “For an art form like dance, that lives among and celebrates all cultures, all people and all bodies – it is particularly disheartening to know that there are so many people that are not yet in the room with us.”
“Our current system is not set up in a way to help them get an early diagnosis or the best possible care,” says Dr Mejia. “The Parkinson’s community really needs to think about and change the diversity in our healthcare teams. Across the continuum, we need greater diversity – racial, ethnic, linguistic and gender – so that patients have a different experience.”
For example, says Dr Mejia, when it comes to clinical research it has been found that lead researchers who speak languages other than English “tend to be more mindful about translating all their clinical research forms into other languages and recruiting people who speak other languages.”
“People are not getting the same care,” says Dr Nabila Dahodwala. In her research into health disparities, Dr Dahodwala found that people who do not speak English in the US and who start to experience symptoms of Parkinson’s are often unsure of where to go or who to tell.
2. Building trust through cultural understanding
When it comes to earning patient trust, Dr Jonathan Jackson, executive director of the Community Access, Recruitment and Engagement (CARE) Research Center at Massachusetts General Hospital, says: “Trust is not where you begin, you begin with empowerment and partnership.
“The best physician is one who can understand you, can understand what’s important to you and can connect you to services, medications, treatment – and can build a plan with you that takes into consideration all of the contextual needs and desires that you have.”
Dr Claudia Martinez, Hispanic outreach coordinator, Muhammad Ali Parkinson Center, says she builds trust with people in the Parkinson’s community by “understanding their cultures, the environment that they live in and where they come from.
“You need to build what I call ‘cultural empathy’, when you’re willing to put yourself in the shoes of that community.”
Dr Mejia shares that in her practice, she starts her appointments by asking patients to talk her through their life as a way of avoiding assumptions.
Dr Altaf Saadi, a neurologist at Massachusetts General Hospital who works with individuals that have fled persecution in their home countries from across the world, says there is a need for a wider community involvement in healthcare to improve trust: “We need to be thinking about doing research that is partnered with community-based organisations. We can’t start with the assumption that people are going to trust us because we’re doctors.”
3. Starting conversations
To improve the inequities in healthcare, we need to have difficult conversations, says Dr Jackson. He emphasises that professionals should not hold back on starting conversations: “Don’t wait until you have perfect representation on your team, all the resources in place and a very detailed plan that is well-funded and sustainable before you reach out to the community.”
Instead, Dr Jackson says, professionals should “be vulnerable” and recognise areas where they may lack understanding. “Do not make assumptions about how the conversation is supposed to go or that somebody should be grateful that you’re there,” he advises.
Tony’s two-wheel tour: a man, a bike and a Parkinson’s promise
Daily diary entries during epic 11-day bike tour across the Alps
7 days ago
New insights on immune cell process and Parkinson’s disease
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…
Could analysing skin oil help diagnose Parkinson’s disease?
Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.
‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia
Dyskinesia is often caused by extended use of the common Parkinson’s medication levodopa – and can be debilitating for those with the condition. Now, researchers in the US may have found a way to suppress these involuntary movements through a protein called ‘sonic hedgehog’. To conduct their study, the team administered levodopa and sonic hedgehog agonists to rodent and non-human primate models of the condition. The results revealed that dopamine neurons use the protein to communicate with other neurons thought to play a role in levodopa-induced dyskinesia. Increased signalling of sonic hedgehog pathways was found to reduce this dyskinesia – providing “novel insight” into its formation and a “potential therapeutic solution”. “What we find,” wrote corresponding study author Professor Andreas Kottmann, “is that in several animal models, by replacing … dopamine together with agonists that mimic the effects of sonic hedgehog, these dyskinesias can be very much suppressed.”